Eosinophilia
Information
- Disease name
- Eosinophilia
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04075331 | Active, not recruiting | Phase 2/Phase 3 | Mepolizumab for COPD Hospital Eosinophilic Admissions Pragmatic Trial | September 7, 2020 | June 30, 2024 |
| NCT02360696 | Completed | Functional Dyspepsia (FD) - Clinical Response to Montelukast in Children | August 2014 | August 2016 | |
| NCT03237221 | Completed | Clinical Characteristics, Treatment and Prognosis of Chest Tightness Variant Asthma | March 1, 2015 | October 23, 2020 | |
| NCT03450083 | Completed | Phase 2 | Benralizumab Effect on Severe Chronic Rhinosinusitis With Eosinophilic Polyposis | July 1, 2017 | February 1, 2020 |
| NCT01524536 | Completed | Phase 4 | Steroid Treatment for Hypereosinophilic Syndrome | February 16, 2012 | December 10, 2020 |
| NCT04252235 | Enrolling by invitation | N/A | Home Air Purification for Eosinophilic COPD | March 15, 2021 | June 30, 2025 |
| NCT06265870 | Not yet recruiting | N/A | Specific Versus Empirical Anthelminthic Treatment in Eosinophilia | April 10, 2024 | December 31, 2025 |
| NCT00001406 | Recruiting | Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia | April 21, 1997 | ||
| NCT00091871 | Recruiting | A Longitudinal Study of Familial Hypereosinophilia (FE): Natural History and Markers of Disease Progression | June 8, 2005 | ||
| NCT03801434 | Recruiting | Phase 2 | Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic Disorders | November 15, 2019 | November 30, 2025 |
| NCT04018118 | Recruiting | Natural History of Hypereosinophilia and Hypereosinophilic Syndromes | May 6, 2019 | May 2031 | |
| NCT04961060 | Recruiting | Drivers of Eosinophilic COPD Exacerbations | July 2021 | January 2025 | |
| NCT05942222 | Recruiting | Phase 4 | A Randomized, Real-world Head-to-head Study of Dupilumab Versus Mepolizumab in Danish CRSwNP Patients | April 27, 2023 | January 2026 |
| NCT00230334 | Terminated | Phase 2 | Phase II Gleevec Idiopathic Hypereosinophilic Syndrome | June 12, 2003 | May 2007 |
| NCT04128371 | Terminated | Phase 2 | Mepolizumab in Episodic Angioedema With Eosinophilia | January 14, 2021 | October 31, 2022 |
| NCT00939263 | Unknown status | Development, Validation and Evaluation of an Adult and Pediatric Eosinophilic Esophagitis Activity Index | January 2011 | December 2016 | |
| NCT04322422 | Unknown status | N/A | Clinical Characteristics and Treatment of Chest Tightness Variant Asthma | June 1, 2020 | December 31, 2022 |
| NCT03989635 | Withdrawn | Phase 2 | Mechanistic Study of Anti-inflammatory Effects of Fevipiprant in Patients With Eosinophilic Asthma. | October 15, 2019 | June 14, 2021 |
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0001880
- MedGen concept unique identifier (MedGen Concept name)
- C0014457
- MedGen unique identifier (MedGen Concept name)
- 41824
- ICD10 preferred id (Insert disease from ICD10)
- D0003268
- ICD10 class code (Insert disease from ICD10)
- D72.1
- MeSH unique ID (MeSH (Medical Subject Headings))
- D004802